Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?
about
Risk assessment and communication tools for genotype associations with multifactorial phenotypes: the concept of "edge effect" and cultivating an ethical bridge between omics innovations and societyPharmacogenetics and pharmacogenomicsClinical use of pharmacogenomic tests in 2009Pharmacogenetics and anaesthetic drugs: Implications for perioperative practicePharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical UseHigh-throughput SNP genotyping by allele-specific PCR with universal energy-transfer-labeled primersCauses of genome instability: the effect of low dose chemical exposures in modern societyProgress towards the integration of pharmacogenomics in practiceDeveloping products for personalized medicine: NIH Research Tools Policy applicationsPharmacogenetics of major depression: insights from level 1 of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial.Advances in pharmacogenetics and pharmacogenomics.Drug-metabolizing enzymes, polymorphisms and interindividual response to environmental toxicants.Serotonin transporter polymorphism and response to SSRIs in major depression and relevance to anxiety disorders and substance abuse.A marker for Stevens-Johnson syndrome ...: ethnicity matters.Advancing the medical management of epilepsy: disease modification and pharmacogenetics.In silico approaches to mechanistic and predictive toxicology: an introduction to bioinformatics for toxicologists.The development of molecular epidemiology to elucidate cancer risk and prognosis: a historical perspectiveThe hunt for new genes and polymorphisms that can control the response to drugs.Murine pharmacogenomics: using the mouse to understand the genetics of drug therapy.Pharmacogenomics for the treatment of dementia.Ethical reflections on pharmacogenetics and DNA banking in a cohort of HIV-infected patients.Implications of pharmacogenetics for individualizing drug treatment and for study design.Pharmacogenetic candidate genes for melanoma.The pharmacogenomics of selective serotonin reuptake inhibitors.Monitoring gene changes during antiepileptic drug therapy to widen the safety window and reduce pharmacoresistance.Steroid hormone receptor gene polymorphisms and osteoporosis: a pharmacogenomic review.Nutrigenomics: concepts and applications to pharmacogenomics and clinical medicine.The rs1142345 in TPMT Affects the Therapeutic Effect of Traditional Hypoglycemic Herbs in Prediabetes.AAPS/RAPS/CAPRA collaborative program: exploring the challenges of drug regulation in a global environment: clinical concerns.Distribution of arylamine N-acetyltransferase 2 (nat2) genotypes among Omanis.Pharmacogenetics and the treatment of functional gastrointestinal disorders.Personalized medicine: Genetic risk prediction of drug response.Pharmacogenetics and interstitial lung disease.Pharmacogenetics: A hope for difficult to treat chronic pain patients.Attitudes of genetic clinicians in Wales to the future development of cancer genetics services.Biomarkers for antiepileptic drug response.Genetic variation in coding regions between and within commonly used inbred rat strains.ADReCS-Target: target profiles for aiding drug safety research and application.Somatic Mutation Analysis of Human Cancers: Challenges in Clinical Practice.Pharmacogenetics: ethical issues.
P2860
Q24289220-5970D9CA-EE41-4CE5-A1D4-FE753EC87BC5Q24564983-DF7F8B76-63B5-413A-9CA4-AC77F5A27C0FQ24657536-6DC314AE-F541-426E-991D-FD86063A61B2Q26771405-AEC7F1DD-9A91-468C-B0BF-CBEBC3BF5751Q28068930-766F27F7-670D-466F-BC32-9EB368047A6FQ28345927-3649933A-1356-4292-B92B-2D5C80B1AAB4Q28388277-6C0924E9-A2E1-4170-9CBC-F255E6901D1AQ28652270-13359796-195B-4E10-80BB-4BED7B3DD6BBQ28749694-4300AFEA-0616-4A34-8928-925AB477A235Q33730306-F8EA6F97-A1B5-4AED-928F-67CCD9112BD9Q34024117-2CEAD9A8-5126-4CC6-9322-5C674FE49066Q34093080-5067A47A-ABBB-4D8C-9D52-29C8A401C1C7Q34188502-EE6ABFCA-2BD8-4C24-A945-E70ECF7CD607Q34485108-68CAD0F8-6266-4491-A368-D26CC8FE8784Q34579490-CC579354-5302-4929-933A-E3DCE9A0E3A4Q34599613-1AEE0598-A696-4B56-94B6-BF75EF79158FQ34793915-38907E77-EA32-4102-B356-8E8F1B42AB7FQ34837113-720C712D-382C-477B-8A0C-E7E1C2BDDF06Q35000912-C03FBD28-2DFC-4FBD-9F6F-ACD4FD801B6EQ35009345-43D18EE6-C1B5-4068-933C-A4C977017E03Q35016337-7CA7246C-5A00-49E8-B300-4A688E216D40Q35102211-40CDFDB6-E26E-4F4A-A088-D4225E0351DDQ35574952-415D3F59-EFE6-40E5-BCBF-110D7CFB384FQ35757723-FB243494-8EE7-4D46-A9BA-57AF1E8A55D3Q36742742-BC576699-714B-4FAC-9293-A543489A0CC2Q36765764-8DA2806B-BBBA-4680-91EF-518B7324F565Q36772839-79C51BCA-23F2-4D5C-BF3D-6B97AF6A206CQ36853578-67B2430F-3E58-4535-817B-123DEACDC1E7Q37361487-F0B193B7-B430-4AE4-8987-1F978B5C68CDQ38478373-0DFBCB1C-ED3C-4654-BD12-78A37F6D96A9Q38661352-5A5787A1-82B3-4210-8AC0-6569744902DDQ38756015-897E3C1E-112A-4DF2-98ED-2F3887E993D4Q38851479-48FAF413-24F0-4F4D-A843-75C0F41DA991Q40121224-B97E99FB-3D0F-44D6-A534-2633C16BCEC2Q40244080-91FB5715-3DA9-4454-84FC-27BB225BF668Q40575037-ACB4BD24-79F9-4229-8349-20EFF317CDECQ41014525-56E75FFD-CD66-40F4-BA9F-A46FC155D46BQ47156223-871641FE-CBDB-4DE7-90DB-79ED1B7CD6CFQ50045424-50672B54-DC4E-4027-A27F-8D2BE7F83860Q53326335-95D24610-7023-4A60-AC55-E6AE2E2225F6
P2860
Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?
@ast
Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?
@en
type
label
Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?
@ast
Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?
@en
prefLabel
Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?
@ast
Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?
@en
P2860
P1433
P1476
Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?
@en
P2093
P2860
P304
P356
10.1034/J.1399-0004.1999.560401.X
P577
1999-10-01T00:00:00Z